Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Lambert

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Experimental Dermatology|October 30, 2016
FRT - FONDATION RENE TOURAINE: An International Foundation For DermatologyThomas C G Bosch, Karsten Zengler, Shruti Naik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2024
The doctor will see you now, in 4 months: A Belgian perspective on waiting times for dermatologic careJo Lambert, Julien Lambert, Koen Roegies, et al.
Pigment Cell Research|September 16, 2005
Different approaches for assaying melanosome transferWerner Berens, Karolien Van Den Bossche, Tae-Jin Yoon, et al.
Bioorganic & Medicinal Chemistry|September 11, 2007
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compoundsBram Baert, Eric Deconinck, Mireille Van Gele, et al.
Cellular and Molecular Life Sciences : CMLS|February 28, 2014
ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteinsMarianthi N Tatari, Bram De Craene, Bieke Soen, et al.
Therapeutic Drug Monitoring|May 21, 2019
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on UstekinumabEline De Keyser, Celine I Busard, Sven Lanssens, et al.
JAMA Dermatology|October 14, 2020
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis: The UltIMMa-1 and UltIMMa-2 Randomized Clinical TrialsMatthias Augustin, Jo Lambert, Carla Zema, et al.
Pigment Cell & Melanoma Research|April 8, 2010
First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo neviNanja A C van Geel, Ilse G Mollet, Sofie De Schepper, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Experimental Dermatology|October 30, 2016
FRT - FONDATION RENE TOURAINE: An International Foundation For DermatologyThomas C G Bosch, Karsten Zengler, Shruti Naik, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2024
The doctor will see you now, in 4 months: A Belgian perspective on waiting times for dermatologic careJo Lambert, Julien Lambert, Koen Roegies, et al.
Pigment Cell Research|September 16, 2005
Different approaches for assaying melanosome transferWerner Berens, Karolien Van Den Bossche, Tae-Jin Yoon, et al.
Bioorganic & Medicinal Chemistry|September 11, 2007
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compoundsBram Baert, Eric Deconinck, Mireille Van Gele, et al.
Cellular and Molecular Life Sciences : CMLS|February 28, 2014
ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteinsMarianthi N Tatari, Bram De Craene, Bieke Soen, et al.
Therapeutic Drug Monitoring|May 21, 2019
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on UstekinumabEline De Keyser, Celine I Busard, Sven Lanssens, et al.
JAMA Dermatology|October 14, 2020
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis: The UltIMMa-1 and UltIMMa-2 Randomized Clinical TrialsMatthias Augustin, Jo Lambert, Carla Zema, et al.
Pigment Cell & Melanoma Research|April 8, 2010
First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo neviNanja A C van Geel, Ilse G Mollet, Sofie De Schepper, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Pageof 14